1. Home
  2. AXSM vs KFY Comparison

AXSM vs KFY Comparison

Compare AXSM & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • KFY
  • Stock Information
  • Founded
  • AXSM 2012
  • KFY 1969
  • Country
  • AXSM United States
  • KFY United States
  • Employees
  • AXSM N/A
  • KFY N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • KFY Diversified Commercial Services
  • Sector
  • AXSM Health Care
  • KFY Consumer Discretionary
  • Exchange
  • AXSM Nasdaq
  • KFY Nasdaq
  • Market Cap
  • AXSM 4.4B
  • KFY 3.6B
  • IPO Year
  • AXSM 2015
  • KFY 1999
  • Fundamental
  • Price
  • AXSM $92.41
  • KFY $71.99
  • Analyst Decision
  • AXSM Strong Buy
  • KFY Buy
  • Analyst Count
  • AXSM 14
  • KFY 4
  • Target Price
  • AXSM $124.57
  • KFY $75.00
  • AVG Volume (30 Days)
  • AXSM 423.1K
  • KFY 330.2K
  • Earning Date
  • AXSM 11-04-2024
  • KFY 09-05-2024
  • Dividend Yield
  • AXSM N/A
  • KFY 2.04%
  • EPS Growth
  • AXSM N/A
  • KFY 3.66
  • EPS
  • AXSM N/A
  • KFY 3.51
  • Revenue
  • AXSM $291,489,000.00
  • KFY $2,738,428,000.00
  • Revenue This Year
  • AXSM $42.50
  • KFY $0.27
  • Revenue Next Year
  • AXSM $69.28
  • KFY $6.17
  • P/E Ratio
  • AXSM N/A
  • KFY $20.61
  • Revenue Growth
  • AXSM 59.73
  • KFY N/A
  • 52 Week Low
  • AXSM $55.02
  • KFY $44.45
  • 52 Week High
  • AXSM $98.40
  • KFY $75.30
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 57.74
  • KFY 56.58
  • Support Level
  • AXSM $89.54
  • KFY $68.08
  • Resistance Level
  • AXSM $96.56
  • KFY $70.51
  • Average True Range (ATR)
  • AXSM 3.25
  • KFY 1.84
  • MACD
  • AXSM -0.04
  • KFY 0.05
  • Stochastic Oscillator
  • AXSM 51.33
  • KFY 77.81

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About KFY Korn Ferry

Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: